The xenon-133 inhalation technique was used to make three measurements of regional cerebral blood flow (CBF) in 34 patients with ruptured cerebral aneurysm: in the acute period (&lt; 14 days) after subarachnoid hemorrhage, in the subacute period (15-30 days), and in the chronic period (12-24 months). The hemispheric mean value of initial slope index was used as the mean CBF. The clinical outcomes were classified into good recovery (GR) (24 cases), moderate disability (MD) (5), and se vere disability (SD) (5) on the Glasgow Outcome Scale. In all periods, the mean CBF significantly correlated with the outcome. GR patients had the highest mean CBF, MD patients the intermediate mean CBF, and SD patients the lowest mean CBF. GR patients had a near-normal mean CBF by the chronic period, while SD patients showed no significant CBF recovery throughout the course.
Introduction
The xenon-133 (133Xe) inhalation method for mea suring cerebral blood flow (CBF) is a noninvasive technique allowing repeated measurements of re gional CBF (rCBF) in the same patient ...... ) We pre viously used this method to perform two consecu tive rCBF measurements before and after intravas cular volume expansion to investigate the effect on CBF in subarachnoid hemorrhage (SAH) patients.") Most recent rCBF studies of SAH patients also em ployed the 133Xe inhalation method and have estab lished relationships between CBF and angiographic vasospasm, symptomatic vasospasm (or delayed ischemic neurological deficits due to vasospasm), and neurological conditions. '0,12,19,20,22,23) Other investigators have also studied CBF changes in SAH patients, but mostly in the acute and/or subacute periods, 8,12," ) with little attention paid to the chronic period (> 1 year after SAH).3,10,23) In the present study, we performed rCBF measurements in SAH patients using the 133Xe inhalation method in the acute, subacute, and chronic periods after ictus, to clarify long-term alterations of CBF in SAH pa tients.
Materials and Methods
The present study included 34 patients, 11 males and 23 females, aged 38-65 years (mean: 54 years) who underwent aneurysm clipping in Kimitsu Central Hospital during [1985] [1986] [1987] . Clinical grades (Hunt and Kosnik) on admission were: 12 cases of grade I or II, 16 of grade III, five of grade IV, and one of grade V. The site of the ruptured aneurysm was con firmed by angiography and surgery as: 12 on the inter nal carotid artery, 11 on the anterior communicating artery, eight on the middle cerebral artery, and one on each of the distal anterior cerebral, anterior choroidal, and posterior inferior cerebellar arteries. This study excluded all patients with multiple aneurysms. Clipping was performed within 3 days of SAH in 25 of 34 patients. The present study also ex cluded patients who developed either hydrocephalus or postoperative complications caused by surgical manipulation such as brain contusion, arterial obliteration, etc. rCBF was measured using the 133Xe inhalation method (Novo Cerebrograph; Novo Diagnostic Systems, Bagsvaerd, Denmark). The procedure employed was described in detail in our previous reports and elsewhere. 14,15,20-22) All 34 patients under went three rCBF measurements: the first in the acute period (< 14 days) after SAH, the second in the subacute period (15-30 days), and the third in the chronic period (12-24 months). CBF was calculated as an initial slope index (ISI), and the hemispheric mean value of ISI was calculated to give the mean CBF in the cerebral hemisphere ipsilateral and con tralateral to the craniotomy. rCBF was measured in eight volunteers (age: 29-48 years) without neuro logical or cardiopulmonary diseases, to obtain the control CBF value.
Two years after SAH, the clinical outcome of each patient was classified, using the Glasgow Outcome Scale (GOS), into good recovery (GR), moderate disability (MD), and severe disability (SD). The present study excluded all clinical outcomes of vegetative or dead.
The group CBF values were compared by analysis of variance and the Bonferroni t-test. The acute, subacute, and chronic CBF data for each group were compared by repeated-measures analysis of variance and the paired t-test corrected by the Bonferroni in equality. A p value < 0.05 was considered statistical ly significant. Table 1 gives the results of rCBF measurement in the 34 SAH patients. The control value of mean CBF ob tained in the eight volunteers (16 hemispheres) was 70 ± 8 ml/ 100 gm/min. Figure 1 indicates the results of statistical analysis for the acute, subacute, and chronic stages. In the acute period, the mean CBF values of three patient groups were significantly lower than the control value in both hemispheres. The differences between each two patient groups were also significant. In the subacute period, the mean CBF values of three pa tient groups were also significantly lower than the control value in both hemispheres. SD patients had the significantly lower mean CBF than both of the GR and MD patients. However, the difference be tween GR and MD patients was not significant. In the chronic period, the mean CBF value of GR pa 
Discussion
The CBF and clinical outcome were clearly related in all periods after SAH. The mean CBF was significant ly higher in patients with favorable outcomes than in patients with poor outcomes. Our results validated the prognostic value of rCBF studies in SAH patients previously reported.","' Previous rCBF studies have demonstrated that patients with decreased CBF achieve poor outcomes, but the extent of CBF reduc tion necessary varied depending on the method employed. Ishii8) reported the critical level as 30 ml/ 100 gm/min.
Using the same 133Xe inhalation method as the present study, Geraud et al.') found the critical flow level to be 35 ml/ 100 gm/min. Our study showed that the critical flow level in the acute period resulting in a poor outcome (SD by GOS) was 40% of the control value (30 ml/ l00 gm/min). Another critical flow level in this study was 70% of the control value (50 ml/100 gm/min). A mean CBF value over this level in the acute period resulted in good outcome (GR by GOS), and CBF suppression in the acute period (30% of the control) was revers ible and disappeared 2 years after SAH. Our results showed that 2 years after SAH, the mean CBF of patients with good outcome (GR and MD by GOS) had significantly recovered, but not in the cases of poor outcome (SD by GOS). In the acute period, CBF may be reduced by various factors in cluding 1) angiographic vasospasm,5,8,12,17,18,20,22) 2) hydrocephalus ,"'19) 3) increased intracranial pres sure,',") 4) brain edema, 5) surgical manipulations such as brain retraction, 1,2,2°,22) and 6) depressed cerebral metabolism.9"") The CBF reduction in the chronic period may be caused by depressed cerebral metabolism. The significant mean CBF recovery in SAH patients with good outcome between the acute and chronic periods suggests that the pathological factors have disappeared by the chronic period. Our results demonstrate that the mean CBF recovers be tween the subacute and chronic periods, not the acute and subacute periods. Most pathological fac tors above may suppress CBF up to 30 days after SAH, but cease by 12-24 months postictus. The CBF fecovery after the subacute period correlates with the frequent neurological recovery in the fol low-up outpatient clinic.
Hyperemia occasionally occurs in SAH pa 3,7,17) In the present study , the mean CBF reduc tion was related to the clinical outcome. No hyperemia was associated with poor outcome. Hyperemia in SAH patients is usually focal and asso ciated with contiguous ischemia. ") The present study used the 133Xe inhalation method to investigate the mean CBF only. Therefore, focal hyperemia found in the border of ischemia will not have been in dicated. CBF in the chronic period after SAH has not been widely investigated. Yamamoto et al.23) reported that the CBF in SAH patients and normal subjects is similar 3 months to 6 years after SAH. Matsuda et al.10) reported that a significant CBF reduction con tinues for several months in elderly SAH patients with good outcome. The present study demonstrated that in the chronic period, GR patients have near-nor mal CBF, but MD and SD patients still have significantly decreased CBF compared to the control value. In the chronic period, the CBF may directly reflect the cerebral metabolism and correlate well with the neurological condition. Therefore, the cerebral metabolism of GR patients may have recovered to normal by the chronic period.
Clearly, the rCBF is related to patient outcome and has prognostic value, especially in the acute period.
